Back to RARE
Hennion & Walsh Asset Management, Inc. → RARE
Hennion & Walsh Asset Management, Inc. RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
5
Latest value
$388K
Q3 2026
Peak value
$2.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2.2M |
| Q4 2025 | $1.4M |
| Q1 2026 | $1.3M |
| Q2 2026 | $850K |
| Q3 2026 | $388K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $388K | 25.8K | — | — |
| Q2 2026 | $850K | 25.5K | — | — |
| Q1 2026 | $1.3M | 60.3K | — | — |
| Q4 2025 | $1.4M | 62.2K | — | — |
| Q3 2025 | $2.2M | 73.8K | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$219.1M
$213.3M
$205.6M
$205.6M
$155.5M